Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders.
about
Blood profile of proteins and steroid hormones predicts weight change after weight loss with interactions of dietary protein level and glycemic indexValsartan improves adipose tissue function in humans with impaired glucose metabolism: a randomized placebo-controlled double-blind trialThe role of adipose tissue and adipokines in obesity-related inflammatory diseasesThe genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE.Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines.Long-term effects of early overnutrition in the heart of male adult rats: role of the renin-angiotensin systemMetabolic syndrome in the pediatric population: a short overviewRole of the Renin-Angiotensin system and aldosterone on cardiometabolic syndrome.Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.Adipose tissue and atherothrombosis.The heart in obesity-hypertension.Metabolic rate regulation by the renin-angiotensin system: brain vs. body.White blood cell count in women: relation to inflammatory biomarkers, haematological profiles, visceral adiposity, and other cardiovascular risk factorsCandesartan cilexetil prevents diet-induced insulin resistance via peroxisome proliferator-activated receptor-γ activation in an obese rat model.Suppression of Resting Metabolism by the Angiotensin AT2 Receptor.Adiposity, type 2 diabetes, and Alzheimer's diseaseEffects of blocking of angiotensin system on the prevalence of metabolic syndrome in type 2 diabetic patientsHigh glucose activates the alternative ACE2/Ang-(1-7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic β-cells.Angiotensin-converting enzyme insertion/deletion polymorphism association with obesity and some related disorders in Egyptian females: a case-control observational study.Total and regional adiposity and cognitive change in older adults: The Health, Aging and Body Composition (ABC) study.Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone.Update on adipose tissue blood flow regulation.The renin-angiotensin system in the pathophysiology of type 2 diabetes.Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.What the genetics of lipodystrophy can teach us about insulin resistance and diabetes.Metabolic syndrome and associated chronic kidney diseases: nutritional interventions.A Review of Potential Marine-derived Hypotensive and Anti-obesity Peptides.Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus.Control of energy balance by the brain renin-angiotensin system.PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Insulin action and lipotoxicity in the development of polycystic ovary syndrome: A review.Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome.Angiotensin type 1a receptors in the forebrain subfornical organ facilitate leptin-induced weight loss through brown adipose tissue thermogenesisCardiovascular complications of type 2 diabetes in youth.Methyl 4-(butyrylamino)-5-methyl-2-nitro-benzoate.Methyl 3-amino-4-butanamido-5-methyl-benzoate.4-Methyl-2-n-propyl-1H-benzimidazole-6-carboxylic acid.Methyl 4-amino-3-methyl-benzoate.Increased total Renin levels but not Angiotensin-converting enzyme activity in obese patients with polycystic ovary syndrome.Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes.Association of body mass index with glomerular filtration rate in Japanese: a cross-sectional study in work-site population.
P2860
Q28477150-500AD3A1-0788-40C8-9111-45C442CE78E8Q28727779-9281B1E5-A2FC-40A5-9B61-1593805B2415Q34022211-6F02BD0E-A035-476D-BDD4-453DBC986CDDQ34123651-F9543C9B-ED6A-46CE-82A2-307C272A40B0Q34635250-9A41D09B-55EE-4B3A-A8CF-6CA42503837CQ34766179-84601E32-1483-4E53-8694-3D2AC7377C19Q34985768-25CCA4C6-2200-43FA-A33A-C663F982B40FQ35113885-2A895D59-EE6E-4957-B251-B4246EA0F97EQ35574423-4839DB24-1D72-498C-B7B1-20F91D009078Q36030434-AB5F9231-4EF5-48D8-8915-355AFB4B3242Q36216822-7006CAF2-DB62-4104-9F4A-784470AA81C4Q36601724-22051FB9-C428-43B6-AEEE-611AB526BFAAQ36985349-BAF8F3DE-CE3A-408C-A44C-391D90D92308Q37001374-41A8A541-A2CB-4671-8658-A172C844428FQ37168385-8E6018BA-9A8F-4020-94A2-D21B1F1A8103Q37250859-2B63332F-F482-41BA-829C-8404CB55DA1FQ37257697-4E6122C5-29A2-4A69-8D39-E06E9D3F57A1Q37265803-A409CC9B-1D48-496C-9043-15CDF3D1D6E1Q37336754-F902132A-8B8B-4B7B-B03E-A28191B58AA8Q37337274-3366A267-0A51-480A-9B1E-DF70968ED9F4Q37396676-A1F84685-573D-453C-93A4-5884A8D963B2Q37982682-48DD5019-33B2-4B63-B96C-D605079C3E65Q38044215-B7707C65-4691-4C29-BE8C-FFBD7AA25DDFQ38136560-619FE4F6-5D82-4823-A276-8310EA4C8D9FQ38136569-ABA70FEE-8D15-4D30-AFBC-B890D8D6006CQ38137667-E6259916-3C7E-49A2-8ABD-C867DB6654A0Q38311340-B73E8031-E906-4925-9C08-7C426D52B15BQ38354900-92B77368-6DC3-4709-96DC-F3A6060809CFQ38400737-34282F87-D067-4873-9CD9-03DB6BF579A3Q38861206-75E76FFD-E73E-43E1-87E5-22519AD004D7Q40133099-92D620CE-D315-44C7-A6E4-620A751E2389Q41129988-20B407E6-AB65-4B89-AC3D-1FDF3AFA472AQ41514778-94E8B204-C247-443C-B537-8832401A60EFQ41970408-2ABCB5EE-BE2D-46D3-BF98-4534583AD976Q42128369-353BD766-1240-419E-895C-9513B9160C70Q42390591-1ACFDE4A-F07F-456F-B85B-741301A85C73Q42403349-7FE49B78-9A5F-4CE8-9409-97C3EF827532Q42759679-A3A7853A-0C75-4FEF-A286-D1E3850F0784Q42816993-5AE06F55-F494-4728-96E0-F4266186981BQ44451538-43A53213-DF22-4358-9F3F-E9BFAABC4115
P2860
Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Possible involvement of the ad ...... and obesity-related disorders.
@ast
Possible involvement of the ad ...... and obesity-related disorders.
@en
type
label
Possible involvement of the ad ...... and obesity-related disorders.
@ast
Possible involvement of the ad ...... and obesity-related disorders.
@en
prefLabel
Possible involvement of the ad ...... and obesity-related disorders.
@ast
Possible involvement of the ad ...... and obesity-related disorders.
@en
P2860
P1433
P1476
Possible involvement of the ad ...... and obesity-related disorders
@en
P2093
P2860
P356
10.1046/J.1467-789X.2003.00091.X
P577
2003-02-01T00:00:00Z